Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add more filters










Database
Language
Publication year range
1.
Sci Rep ; 5: 16828, 2015 Nov 18.
Article in English | MEDLINE | ID: mdl-26577048

ABSTRACT

Sorcin is an essential penta-EF hand calcium binding protein, able to confer the multi-drug resistance phenotype to drug-sensitive cancer cells and to reduce Endoplasmic Reticulum stress and cell death. Sorcin silencing blocks cell cycle progression in mitosis and induces cell death by triggering apoptosis. Sorcin participates in the modulation of calcium homeostasis and in calcium-dependent cell signalling in normal and cancer cells. The molecular basis of Sorcin action is yet unknown. The X-ray structures of Sorcin in the apo (apoSor) and in calcium bound form (CaSor) reveal the structural basis of Sorcin action: calcium binding to the EF1-3 hands promotes a large conformational change, involving a movement of the long D-helix joining the EF1-EF2 sub-domain to EF3 and the opening of EF1. This movement promotes the exposure of a hydrophobic pocket, which can accommodate in CaSor the portion of its N-terminal domain displaying the consensus binding motif identified by phage display experiments. This domain inhibits the interaction of sorcin with PDCD6, a protein that carries the Sorcin consensus motif, co-localizes with Sorcin in the perinuclear region of the cell and in the midbody and is involved in the onset of apoptosis.


Subject(s)
Calcium-Binding Proteins/chemistry , Calcium-Binding Proteins/metabolism , Calcium/chemistry , Calcium/metabolism , Signal Transduction , Amino Acid Motifs , Amino Acid Sequence , Annexins/metabolism , Apoptosis Regulatory Proteins/chemistry , Apoptosis Regulatory Proteins/metabolism , Binding Sites , Cell Surface Display Techniques , EF Hand Motifs , Edetic Acid/chemistry , Edetic Acid/metabolism , Humans , Ions/chemistry , Ions/metabolism , Models, Molecular , Molecular Conformation , Molecular Sequence Data , Peptides/chemistry , Peptides/metabolism , Position-Specific Scoring Matrices , Protein Binding , Protein Interaction Domains and Motifs , Protein Transport , Solvents , Structure-Activity Relationship
2.
PLoS One ; 9(1): e85438, 2014.
Article in English | MEDLINE | ID: mdl-24427308

ABSTRACT

Sorcin, a protein overexpressed in many multi-drug resistant cancers, dynamically localizes to distinct subcellular sites in 3T3-L1 fibroblasts during cell-cycle progression. During interphase sorcin is in the nucleus, in the plasma membrane, in endoplasmic reticulum (ER) cisternae, and in ER-derived vesicles localized along the microtubules. These vesicles are positive to RyR, SERCA, calreticulin and Rab10. At the beginning of mitosis, sorcin-containing vesicles associate with the mitotic spindle, and during telophase are concentrated in the cleavage furrow and, subsequently, in the midbody. Sorcin regulates dimensions and calcium load of the ER vesicles by inhibiting RYR and activating SERCA. Analysis of sorcin interactome reveals calcium-dependent interactions with many proteins, including Polo-like kinase 1 (PLK1), Aurora A and Aurora B kinases. Sorcin interacts physically with PLK1, is phosphorylated by PLK1 and induces PLK1 autophosphorylation, thereby regulating kinase activity. Knockdown of sorcin results in major defects in mitosis and cytokinesis, increase in the number of rounded polynucleated cells, blockage of cell progression in G2/M, apoptosis and cell death. Sorcin regulates calcium homeostasis and is necessary for the activation of mitosis and cytokinesis.


Subject(s)
Calcium Signaling , Calcium-Binding Proteins/metabolism , Cell Cycle Proteins/metabolism , Mitosis/physiology , Protein Serine-Threonine Kinases/metabolism , Proto-Oncogene Proteins/metabolism , Transport Vesicles , Amino Acid Sequence , Animals , Calcium-Binding Proteins/chemistry , Calcium-Binding Proteins/genetics , Cell Line , Endoplasmic Reticulum/metabolism , Gene Expression , Gene Silencing , Humans , Mice , Models, Molecular , Molecular Sequence Data , Phosphorylation , Protein Binding , Protein Conformation , Protein Interaction Mapping , Protein Transport , Rats , Sequence Alignment , Polo-Like Kinase 1
3.
Proc Natl Acad Sci U S A ; 110(24): 9794-9, 2013 Jun 11.
Article in English | MEDLINE | ID: mdl-23716697

ABSTRACT

ADP-ribosylation is a posttranslational modification that modulates the functions of many target proteins. We previously showed that the fungal toxin brefeldin A (BFA) induces the ADP-ribosylation of C-terminal-binding protein-1 short-form/BFA-ADP-ribosylation substrate (CtBP1-S/BARS), a bifunctional protein with roles in the nucleus as a transcription factor and in the cytosol as a regulator of membrane fission during intracellular trafficking and mitotic partitioning of the Golgi complex. Here, we report that ADP-ribosylation of CtBP1-S/BARS by BFA occurs via a nonconventional mechanism that comprises two steps: (i) synthesis of a BFA-ADP-ribose conjugate by the ADP-ribosyl cyclase CD38 and (ii) covalent binding of the BFA-ADP-ribose conjugate into the CtBP1-S/BARS NAD(+)-binding pocket. This results in the locking of CtBP1-S/BARS in a dimeric conformation, which prevents its binding to interactors known to be involved in membrane fission and, hence, in the inhibition of the fission machinery involved in mitotic Golgi partitioning. As this inhibition may lead to arrest of the cell cycle in G2, these findings provide a strategy for the design of pharmacological blockers of cell cycle in tumor cells that express high levels of CD38.


Subject(s)
Adenosine Diphosphate Ribose/metabolism , Alcohol Oxidoreductases/metabolism , Brefeldin A/metabolism , DNA-Binding Proteins/metabolism , ADP-ribosyl Cyclase/metabolism , ADP-ribosyl Cyclase 1/metabolism , Alcohol Oxidoreductases/chemistry , Animals , Binding Sites , Binding, Competitive , Blotting, Western , Brefeldin A/pharmacology , Cytosol/drug effects , Cytosol/metabolism , DNA-Binding Proteins/chemistry , HeLa Cells , Humans , Membrane Glycoproteins/metabolism , Models, Molecular , NAD/chemistry , NAD/metabolism , Protein Binding , Protein Processing, Post-Translational/drug effects , Protein Structure, Tertiary , Rats
4.
J Cell Physiol ; 228(9): 1907-21, 2013 Sep.
Article in English | MEDLINE | ID: mdl-23460338

ABSTRACT

We report here that C6orf89, which encodes a protein that interacts with bombesin receptor subtype-3 and accelerates cell cycle progression and wound repair in human bronchial epithelial cells (Liu et al., 2011, PLoS ONE 6: e23072), encodes one soluble and two type II membrane proteins that function as histone deacetylases (HDAC) enhancers. Soluble 34/64sp is selectively targeted to the nucleolus and is retained in nucleolar organiser regions (NORs) in mitotic cells. Nucleolar 34/64sp is integrated into the ribosomal gene transcription machinery, colocalises and coimmunoprecipitates with the Pol I transcription factor UBF, and undergoes a dramatic relocalisation to the nucleolus upon the arrest of rDNA transcription, protein synthesis and PI3K/mTORC2 signalling. Membrane 42/116mp localises to the Golgi and the midbody, and its controlled ectopic expression provokes the disruption of the Golgi cisternae and hinders the separation of daughter cells and the completion of mitosis. The latter effect is also produced by the microinjection of an affinity-purified amfion antibody. The identification of C60rf89 as a gene that encodes three distinct proteins with the capacity to enhance the activity of histone deacetylases (HDACs) in the nucleolus, the Golgi and the midbody provides new information regarding the components of the acetylome and their capacity to interact with different functional groups in the cell.


Subject(s)
Cell Nucleus/metabolism , Golgi Apparatus/metabolism , Nucleolus Organizer Region/metabolism , Proteins/genetics , Cell Cycle/genetics , Cell Nucleus/genetics , DNA, Ribosomal/genetics , DNA, Ribosomal/metabolism , DNA-Binding Proteins , Enhancer Elements, Genetic , Golgi Apparatus/genetics , HeLa Cells , Histone Deacetylases/genetics , Histone Deacetylases/metabolism , Humans , Mitosis/genetics , Nucleolus Organizer Region/genetics , Phosphatidylinositol 3-Kinases/metabolism , Proteins/metabolism , Receptors, Bombesin/genetics , Receptors, Bombesin/metabolism
5.
J Cell Physiol ; 218(2): 416-26, 2009 Feb.
Article in English | MEDLINE | ID: mdl-18932217

ABSTRACT

We have previously reported the physical interaction between Daxx, the adaptor protein that mediates activation of the Jun amino-terminal kinase (JNK), and GLUT4, the insulin-dependent glucose transporter, interaction that involves their C-domains. Co-immunoprecipitation and two-hybrid-based protein-protein interaction studies show now that Daxx and GLUT4 interact with JNK1 through D-sites in their NH(2)-(aa 1-501) and large endofacial loop, respectively. Serum deprivation strongly enhances the association of JNK1 with Daxx and dissociates the kinase from GLUT4. SP600125, a potent JNK1 inhibitor, reduces the JNK1 activity associated with GLUT4 and the phosphorylation of two minor GLUT4 species in serum-starved 3T3-L1 adipocytes. In addition, Daxx interacts with kinesin KIF5B through the 6xTPR domain of the kinesin light chain, a domain engaged in the grab hold of protein cargo by kinesin motors that codistribute with JNK. Depletion of Daxx in 3T3-L1 adipocytes provokes the partial translocation of the GLUT4 retained in the GLUT4 storage compartment to endosomes.


Subject(s)
Carrier Proteins/metabolism , Glucose Transporter Type 4/metabolism , Intracellular Signaling Peptides and Proteins/metabolism , Kinesins/metabolism , Mitogen-Activated Protein Kinase 8/metabolism , Nuclear Proteins/metabolism , 3T3-L1 Cells , Adipocytes/drug effects , Adipocytes/enzymology , Animals , Anthracenes/pharmacology , Carrier Proteins/chemistry , Co-Repressor Proteins , Glucose Transporter Type 4/chemistry , Humans , Immunoprecipitation , Insulin Receptor Substrate Proteins/metabolism , Intracellular Signaling Peptides and Proteins/chemistry , Mice , Microtubules/drug effects , Microtubules/metabolism , Mitogen-Activated Protein Kinase 8/antagonists & inhibitors , Mitogen-Activated Protein Kinase 8/chemistry , Molecular Chaperones , Nuclear Proteins/chemistry , Phosphorylation/drug effects , Protein Binding/drug effects , Protein Structure, Secondary , Protein Structure, Tertiary , Protein Transport/drug effects , Rats , Serum
SELECTION OF CITATIONS
SEARCH DETAIL
...